Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-01-14

FDA Approved: CIBINQO — Original Application (U.S. Pharmaceuticals)

View source ↗

Summary

FDA approved CIBINQO (abrocitinib) through an original New Drug Application from U.S. Pharmaceuticals. It is indicated for the treatment of moderate-to-severe a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cibinqo (abrocitinib)

Snippet

ORIG AP for CIBINQO (ABROCITINIB)